CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 59 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $90,000 | +9.8% | 22,433 | 0.0% | 0.00% | – |
| Q4 2018 | $82,000 | -78.6% | 22,433 | -50.0% | 0.00% | – |
| Q3 2018 | $384,000 | +54.8% | 44,866 | +98.6% | 0.00% | – |
| Q2 2018 | $248,000 | +38.5% | 22,596 | +45.1% | 0.00% | – |
| Q1 2018 | $179,000 | +11.2% | 15,568 | 0.0% | 0.00% | – |
| Q4 2017 | $161,000 | -35.1% | 15,568 | 0.0% | 0.00% | – |
| Q3 2017 | $248,000 | +31.9% | 15,568 | 0.0% | 0.00% | – |
| Q2 2017 | $188,000 | +154.1% | 15,568 | +338.4% | 0.00% | – |
| Q1 2017 | $74,000 | +45.1% | 3,551 | 0.0% | 0.00% | – |
| Q4 2016 | $51,000 | -12.1% | 3,551 | 0.0% | 0.00% | – |
| Q3 2016 | $58,000 | +13.7% | 3,551 | 0.0% | 0.00% | – |
| Q2 2016 | $51,000 | – | 3,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
| Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
| CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
| BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
| EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
| Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
| Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
| Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
| ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
| Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |